AgeX Therapeutics Inc. (AGE)
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 7:59 PM
-11.90% (1D)
| Bid | n/a |
| Market Cap | 27.76M |
| Revenue (ttm) | 116K |
| Net Income (ttm) | -20.96M |
| EPS (ttm) | -482.53 |
| PE Ratio (ttm) | -0.02300375106211013 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 3,681 |
| Avg. Volume (20D) | 3,980 |
| Open | 12.59 |
| Previous Close | 12.60 |
| Day's Range | 11.10 - 12.59 |
| 52-Week Range | 10.90 - 35.17 |
| Beta | 1.19 |
About AGE
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-base...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 29, 2018
Employees 4
Stock Exchange AMEX
Ticker Symbol AGE
Website https://www.agexinc.com